1. |
Price AS. Primary and secondary prevention of colorectal cancer [J]. Gastroenterol Nurs, 2003; 26(2)∶73.
|
2. |
賀立績, 王桂芳, 黃瑞德, 等. 1990 年-1992 年山西陽城居民惡性腫瘤死亡情況分析 [J]. 腫瘤研究與臨床, 2000; 12(6)∶430.
|
3. |
陳建順, 陳禮慈, 游建旺, 等. 長樂市中年人惡性腫瘤死亡分析 [J]. 中國腫瘤, 2001; 10(9)∶514.
|
4. |
林金榮, 林鴻, 周殿元, 等. 應(yīng)用銀染PCR-SSCP檢測結(jié)、直腸癌組織及糞便抑癌基因點突變 [J]. 中華流行病雜志, 1998,19(5)∶B326.
|
5. |
Nollau P, Moser C, Weinland G, et al. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR [J]. Int J Cancer, 1996; 66(3)∶332.
|
6. |
Jais P, Kapel N, Chosidow D, et al. Detection of protein p53 in the stool of patients with colorectal cancer [J]. Gastroenterol Clin Biol, 1997; 21(10)∶754.
|
7. |
Hasegawa H, Ueda M, Furukawa K, et al. p53 gene mutations in early colorectal carcinoma. De novo vs. adenoma-carcinoma sequence [J]. Int J Cancer, 1995; 64(1)∶47.
|
8. |
胡成平, 鄭智遠, 楊紅忠, 等. 癌性胸腔積液K-ras基因突變檢測及臨床應(yīng)用 [J]. 中國現(xiàn)代醫(yī)學(xué)雜志, 1999; 9(11)∶5.
|
9. |
Strul H, Arber N. Fecal occult blood test for colorectal cancer screening [J]. Ann Oncol, 2002; 13(1)∶51.
|
10. |
Cooper GS, Yuan Z, Veri L, et al. Colorectal carcinoma sc-reening attitudes and practices among primary care physicians in counties at extremes of either high or low cancer case-fatality [J]. Cancer, 1999; 86(9)∶1669.
|
11. |
Ahlquist DA. Fecal occult blood testing for colorectal cancer. Can we afford to do this? [J]. Gastroenterol Clin North Am, 1997; 26(1)∶41.
|
12. |
Sidransky D, Tokino T, Hamilton SR, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors [J]. Science, 1992; 256(5053)∶102.
|
13. |
Ratto C, Flamini G, Sofo L, et al. Detection of oncogene mutation from neoplastic colonic cells exfoliated in feces [J]. Dis Colon Rectum, 1996; 39(11)∶1238.
|
14. |
范如英, 李世榮, 吳霞, 等. 糞便大腸癌脫落細胞形態(tài)學(xué)觀察、 DNA定量及p53蛋白表達的初步研究 [J]. 中華消化雜志, 2000; 20(4)∶269.
|
15. |
Nollau P, Moser C, Weinland G, et al. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR [J]. Int J Cancer, 1996; 66(3)∶332.
|
16. |
倪升發(fā). K-ras基因與大腸癌關(guān)系的研究進展 [J]. 醫(yī)學(xué)綜述, 2006; 12(1)∶15.
|
17. |
徐亮, 盧光宇. 大腸癌ras p21表達和DNA含量定量分析 [J]. 中國普外基礎(chǔ)與臨床雜志, 1998; 5(1)∶4.
|
18. |
高楓, 唐衛(wèi)中, 李衛(wèi). 中國人散發(fā)性大腸癌K-ras基因突變的研究 [J]. 中華實驗外科雜志, 2005; 22(1)∶65.
|
19. |
Beranek M, Bures J, Palicka V, et al. A relationship between K-ras gene mutations and some clinical and histologic variables in patients with primary colorectal carcinoma [J]. Clin Chem Lab Med, 1999; 37(7)∶723.
|
20. |
王一理, 王劍利, 李琳琳. 癌基因·抑癌基因·腫瘤相關(guān)基因 [A]. 見: 司履生主編. 癌基因 抑癌基因 腫瘤相關(guān)基因 [M]. 第1版. 西安: 陜西科學(xué)技術(shù)出版社, 2002∶63.
|